Engineered AAV Vectors Cross Blood-Brain Barrier in Monkeys
AAV9-Retro mediates efficient transduction with axon terminal absorption and blood–brain barrier transportation | Molecular Brain | Full Text
Frontiers | A Multifaceted Approach to Optimizing AAV Delivery to the Brain for the Treatment of Neurodegenerative Diseases
Reversibly Modulating the Blood–Brain Barrier by Laser Stimulation of Molecular-Targeted Nanoparticles | Nano Letters
Frontiers | A Multifaceted Approach to Optimizing AAV Delivery to the Brain for the Treatment of Neurodegenerative Diseases
Researchers engineer AAV vectors to cross the blood-brain barrier
AAV9: a potential blood-brain barrier buster: Molecular Therapy
The human brain endothelial barrier: transcytosis of AAV9, transduction by AAV2 - Weber‐Adrian - 2017 - Journal of Neurochemistry - Wiley Online Library
Improved AAV could cross BBB and deliver gene therapies to brain
Apolipoprotein E, low-density lipoprotein receptor, and immune cells control blood-brain barrier penetration by AAV-PHP.eB in mice
Delivering Genes Across the Blood-Brain Barrier | www.caltech.edu
Beyond the Blood Brain Barrier: PHP.B Enters the Central Nervous System Via the LY6A Receptor
Delivering Genes Across the Blood-Brain Barrier - BioTechniques
Sci. Pharm. | Free Full-Text | Overcoming the Blood–Brain Barrier. Challenges and Tricks for CNS Drug Delivery
Blood-brain barrier (BBB) in the context of CNS-targetting... | Download Scientific Diagram
Crossing the blood-brain barrier with AAV vectors | SpringerLink
Press Release August 24 2020 - STEM BIOMEDICAL
BBB-crossing adeno-associated virus vector: An excellent gene delivery tool for CNS disease treatment - ScienceDirect
.png "AAV-PHP.B Administration Results in a Differential Pattern of CNS Biodistribution in Non-human Primates Compared with Mice | ASGCT - American Society of Gene & Cell Therapy")
AAV-PHP.B Administration Results in a Differential Pattern of CNS Biodistribution in Non-human Primates Compared with Mice | ASGCT - American Society of Gene & Cell Therapy
Research – Gradinaru Lab
A brain microvasculature endothelial cell‐specific viral vector with the potential to treat neurovascular and neurological diseases | EMBO Molecular Medicine
AAVs CREATed for Gene Delivery to the CNS and PNS
